More Archives - Keta Medical Center https://ketamc.com/blog/category/more/ Fri, 17 Jul 2026 21:40:53 +0000 en-US hourly 1 https://wordpress.org/?v=7.1 https://ketamc.com/wp-content/uploads/2026/06/cropped-favicon-32x32.webp More Archives - Keta Medical Center https://ketamc.com/blog/category/more/ 32 32 Scrolling Your Way to Anxiety? How Social Media Impacts Mental Health https://ketamc.com/blog/scrolling-your-way-to-anxiety-how-social-media-impacts-mental-health/ Mon, 29 Jun 2026 18:09:54 +0000 https://ketamc.com/?p=18213 Social media is woven into daily life, but its impact on mental health is complex. From constant comparison to dopamine-driven design, research shows how excessive or passive use can increase anxiety and depression—and what healthier digital habits can help.

The post Scrolling Your Way to Anxiety? How Social Media Impacts Mental Health appeared first on Keta Medical Center.

]]>
Perhaps you’ve seen one of the many documentaries showing the dark side of social media, such as The Social Dilemma. Perhaps you were shocked that so many people who created the social media companies today regret what they’ve created, in part because of the damage it’s done to people’s mental health.

The clinical research backs it up: Studies have consistently found that frequent social media use is linked to increased levels of anxiety and depression, particularly among teens and young adults. And it’s about more than just the amount of time spent on TikTok or Instagram.

The platforms are designed in a way that causes them to be addictive, activating the brain’s reward system with likes and comments. When users don’t get that feedback, it can leave them feeling inadequate or rejected. The design of social media actually affects brain chemistry, triggering dopamine, a neurotransmitter linked to pleasure and motivation.

With nearly 5 billion users worldwide and daily usage averaging over two hours, social media has become part of the fabric of our daily lives. While it can sometimes be a means of connection, the psychological toll of constant online engagement is clear.


The Threat Of Constant Comparison

Scrolling through curated content—vacations, career wins, “perfect” bodies—can distort reality. Social media is often called a “highlight reel,” where users showcase only their best moments. Daily exposure to filtered images and idealized lifestyles can spark self-doubt and lower self-esteem.

Adolescents are particularly vulnerable. With social media, teens get a front-row seat to their own exclusion. A seventh grader who gets left out of plans can actually watch the activities he or she isn’t a part of unfold in real time on someone’s story.


Less Social Media Time, Better Mental Health

A study from Iowa State University offered compelling evidence for the benefits of simply reducing social media use. College students who limited their screen time to 30 minutes per day for two weeks reported significantly lower levels of anxiety, depression, and loneliness than a control group. Several participants reported better sleep, improved focus, and stronger in-person connections after reducing their online time.

They also showed increased positive emotions, such as excitement and pride. Interestingly, even students who occasionally exceeded the 30-minute cap still experienced these benefits, suggesting that effort and user awareness may be more important than strict screen time limits.


How You Use Social Media Matters

Most Americans believe social media does more harm than good, yet many still report positive feelings while using it. A 2022 poll found that 72% of users felt connected and happy, while 63% believed social media was ultimately harmful.

This contradiction highlights a key finding from researchers: the effects of social media aren’t universally good or bad. They depend on how people use it. While some types of use can support mental wellbeing, many others can cause real harm.

Passive scrolling, especially when used to avoid social interaction, tends to worsen mood. In fact, studies strongly link it to increased depressive symptoms. On the other hand, using social media to enhance existing relationships or share meaningful content may have positive effects, particularly among older adults.

There’s also evidence that more time spent on social media increases the risk of anxiety and depression in a clear dose-response pattern: the more time adolescents spent on the platforms, the more likely they were to experience symptoms.


Practical Tips For A Healthier Digital Life

Mental health professionals recommend several strategies to build healthier social media habits, including:
  • Limiting daily screen time using app settings or timers.
  • Curating your feed to avoid triggering or negative content.
  • Prioritizing real-world connections through hobbies, exercise, and in-person time.
  • Being mindful of how different platforms make you feel.
Longer periods of “digital detox” have also been found to be effective in improving mental health. Families are encouraged to establish phone-free zones and times, especially at night, and to respectfully monitor teen use. As in any other type of behavior, parents are the role model: Kids are more likely to adopt healthy habits when parents do the same.


Supporting Mental Health In The Digital Age

Social media platforms evolve fast, and it’s crucial for both individuals and providers to stay aware of the dynamic, often harmful ways they influence our mental health.

If you or someone you know is feeling overwhelmed by anxiety, depression, or digital burnout, help is available. At Keta Medical Center, we understand that today’s mental health landscape includes digital life.

We support patients in navigating these modern stressors with evidence-based care. Schedule your free consultation today.
Schedule a free consultation

The post Scrolling Your Way to Anxiety? How Social Media Impacts Mental Health appeared first on Keta Medical Center.

]]> When AI Becomes Your Therapist: The Hidden Risks of Using ChatGPT for Mental Health https://ketamc.com/blog/ai-therapy-risks-chatgpt-mental-health/ Thu, 25 Jun 2026 05:00:50 +0000 https://ketamc.com/?p=17276 As more people turn to AI tools like ChatGPT for emotional support, mental health professionals are raising serious concerns. This article explores the clinical risks, research findings, and real-world consequences of relying on AI instead of human care.

The post When AI Becomes Your Therapist: The Hidden Risks of Using ChatGPT for Mental Health appeared first on Keta Medical Center.

]]>

For many people navigating depression, anxiety, PTSD, or other mood disorders, it’s not always easy to ask for help. Feelings of shame, fear of stigma, or past negative experiences can make reaching out feel daunting. When you add in long waitlists, financial barriers, or other difficulties accessing care, it’s understandable why people are increasingly turning to artificial intelligence for advice, reassurance and even therapy.

The Dangers of AI “Support”

AI-tools like ChatGPT offer 24/7 availability, instant responses, and a tone that is hard coded to be empathetic and nonjudgmental. It can be very tempting to interact with AI tools as if they were your therapist, despite the fact that they are not trained, qualified, or in a safe position to play that role.

For someone isolated or overwhelmed, talking to a chatbot can feel easier than facing a real person. But while an AI chatbot may simulate concern, it can’t replace clinical insight and true empathy. In fact, it can even introduce new risks, fostering emotional dependence by creating a false sense of intimacy. That’s something especially risky for people in crisis.

This also applies to popular purpose-built mental health chatbots like Wysa, Abby or Woebot. A recent Stanford study examining popular AI therapy tools found that these systems not only fell short of human therapists in effectiveness, but in some cases introduced harmful bias, reinforced stigma, and generated responses that could be dangerous for vulnerable users. Mental health experts have warned the way AI mimics a trusted companion increases the risk that users will believe and act on harmful misinformation. A tone of validation combined with incorrect advice can make bad recommendations seem both credible and personal.

Troubling cases have shown that AI chatbots have responded to users with detailed guidance on suicide methods rather than discouraging self-harming thought patterns, for example. Without the ability to accurately diagnose or treat, and with a tendency to fabricate content, AI-generated “guidance” can quickly veer into very dangerous territory.

What The Research Reveals

Recent studies have proven the serious risks of relying on AI for mental health. Research has shown that language models like ChatGPT are capable of generating false or misleading information with a tone of confidence, making it difficult for users to detect errors, especially when they’re emotionally vulnerable.

In clinical simulations, AI tools failed to detect or respond appropriately to suicidal ideation. In some cases, chatbots enabled dangerous behavior or reinforced delusional thinking instead of challenging it, failing to meet even the most basic safety standards for therapeutic care.

The Stanford study found consistent patterns of bias when it tested several popular therapy bots. AI responses showed more stigma toward certain mental illnesses, like schizophrenia and alcohol use disorder, than toward others like depression. This algorithmic bias could lead users to feel judged or shamed based on the nature of their condition, further discouraging them from seeking legitimate help.

What I’ve Seen in Practice: How AI Can Misguide Vulnerable Patients

As a mental health provider, I’ve already seen the dangers of consulting with AI tools firsthand. Some of my patients have turned to ChatGPT for advice, sometimes with harmful consequences.

In one case, a patient emailed me asking if it was safe to stop all of his psychiatric treatments, including his prescribed medication and Spravato. He had consulted ChatGPT, and the tool had told him to stop. It claimed that since the medication “wasn’t working,” he should discontinue it. What ChatGPT didn’t know is that he was on a medication that carries a risk of withdrawal and must be tapered under medical supervision.

I’ve also had patients come in asking about treatments recommended by an AI tool that simply weren’t appropriate given their medical history. These tools simply can’t understand the whole picture. They don’t know your past, your diagnoses, or how your body reacts to different medications.

This is exactly why turning to AI chatbots for mental health guidance can be so dangerous. Getting advice from these tools may feel reassuring, but they lack the clinical judgment, contextual awareness, and training that real human providers bring to every decision. And, of course, the empathy.

What AI Can’t Do And Why Human Help Matters

Scientific findings show that AI models are simply not capable of functioning as therapists. They do not understand human nuance, cannot recognize nonverbal cues, and do not customize their responses based on an individual’s personal history or risk factors. Unlike clinicians, AI does not know when to escalate a concern or refer someone for urgent care.

That said, AI can have a place in mental health care as long as it’s used with appropriate boundaries. I’ve had patients use ChatGPT for journal prompts or to help articulate their feelings in ways that improve communication with their therapist. Some find it helpful for reinforcing grounding techniques when they’re feeling upset.

In these specific, supportive roles, AI can serve as a tool, but never as a substitute for a human therapist. AI tools don’t ask follow-up questions. They don’t know your medical history. In the end, an AI tool is still a computer. It can process information and generate a response, even mimicking warmth or understanding. But it doesn’t truly understand the nuance of emotion or the depth of human experience.

Overreliance on AI can actually worsen the symptoms that drove someone to seek it out in the first place. Using a chatbot as a substitute for human interaction may increase social isolation, a well-known risk factor for depression. In high-risk individuals, AI’s emotionally detached or inaccurate responses can even exacerbate suicidal ideation. According to research, even the best-designed language models still hallucinate facts, misinterpret context, and underperform in critical psychiatric evaluations.

Real Support Comes From Real People

AI tools may be helpful in supporting clinicians behind the scenes, helping with paperwork or training—but they certainly cannot replace professional human judgment or care. Feeling misunderstood or unsure about treatment shouldn’t mean you need to go through it alone or turn to artificial intelligence for answers. Real support comes from real people!

Here at Keta, my fellow staff members are highly trained — doctors, nurses, psychiatrists and clinicians who are here to help our patients find support, and relief that lasts.

Contact us to learn more and explore whether ketamine therapy is right for you.

Schedule a free consultation.

The post When AI Becomes Your Therapist: The Hidden Risks of Using ChatGPT for Mental Health appeared first on Keta Medical Center.

]]> Trump’s Psychedelic Executive Order: What It Means for Mental Health Treatment https://ketamc.com/blog/psychedelic-executive-order/ Wed, 10 Jun 2026 15:06:14 +0000 https://ketamc.com/?p=18860 The April 2026 executive order marks one of the most significant federal shifts in mental health policy in decades. Here's what it actually does, what it doesn't, and what it could mean for the future of psychedelic-assisted therapy.

The post Trump’s Psychedelic Executive Order: What It Means for Mental Health Treatment appeared first on Keta Medical Center.

]]>

On April 18, 2026, President Donald Trump signed an executive order that marked one of the most significant federal policy shifts in mental health treatment in decades. For patients, clinicians, and providers working in the field of innovative psychiatry, this development is worth paying close attention to, not because it changes what is available today, but because it signals a meaningful acceleration in what may become available in the years ahead.

 

What is Trump’s new executive order on psychedelics?

 

The executive order, formally titled Accelerating Medical Treatments for Serious Mental Illness, directs multiple federal agencies to reduce barriers to the research, clinical review, and (where appropriate) the approval of psychedelic compounds as treatments for serious mental illness.

The scale of the problem it’s designed to address is significant. According to the order itself, more than 14 million American adults currently live with a serious mental illness, defined as a diagnosable condition that substantially interferes with a person’s ability to function in daily life. 

Approximately 8 million of those individuals are on prescription medication for their conditions. Among U.S. military veterans, the crisis is particularly severe: an estimated 6,000 veterans die by suicide each year, a figure that has driven bipartisan urgency around exploring new treatment approaches.

The order contains five core directives: fast-tracking psychedelic therapies through priority FDA review vouchers, expanding patient access under Right to Try, allocating $50 million in matching research funding, requiring cross-agency data sharing, and accelerating rescheduling after Phase 3 trials.

It’s important to note that the order itself doesn’t approve any psychedelic compound for medical use. It does not create enforceable rights for patients or providers. 

What it does is meaningfully reshape the regulatory environment and signal a substantial directional shift in federal policy.

 

What does the executive order mean for the future of psychedelic medicine?

 

For anyone following psychedelic medicine closely, the implications of the April 2026 executive order are significant, though they will take time to materialize in clinical practice. Here is how we see the key takeaways:

  • Shorter path to FDA approval for compounds like psilocybin. The combination of Breakthrough Therapy designation, the Commissioner’s National Priority Vouchers, and the executive order’s rescheduling directive creates a much more compressed timeline than previously existed. Psilocybin compounds from Compass Pathways and the Usona Institute are now among the first psychedelics to receive expedited review consideration, an unprecedented step.
  • Clinical access through formal channels. The Right to Try expansion means that eligible patients (specifically those with serious, treatment-resistant conditions) may be able to access certain investigational psychedelic compounds sooner, under physician supervision and through established clinical frameworks, rather than through unregulated or international settings.
  • Accelerated research and higher-quality evidence. The $50 million federal matching fund and the mandated data-sharing agreements between HHS, the FDA, and the VA are expected to significantly increase both the volume and quality of clinical evidence supporting psychedelic therapies. This evidence base is what ultimately drives FDA approval decisions.
  • Ibogaine vs. psilocybin: a meaningful distinction. Ibogaine is the more prominently named compound in the executive order, particularly in the context of veteran PTSD and depression treatment. It carries known safety considerations, including cardiac risks, that make its clinical pathway more complex. Psilocybin, by contrast, has a broader and more advanced clinical trial pipeline for general mental health indications, including treatment-resistant depression and major depressive disorder, but it remains a Schedule I substance and is not yet FDA-approved. The two compounds are at different stages, with different risk profiles, and should not be conflated.

 

How Keta Medical Center is thinking about the executive order

 

We’ve been following developments in psychedelic medicine closely for quite some time, and the April 2026 executive order represents a meaningful step forward in expanding access to innovative mental health treatments. At Keta Medical Center, we view this policy shift with both cautious optimism and a grounded sense of what it does (and doesn’t as of yet) mean for patients.

We’re veterans in this space. As a leading ketamine center in New York and New Jersey, for years, we have provided evidence-based treatments for depression, anxiety, post-traumatic stress disorder (PTSD), and chronic pain using ketamine infusions and Spravato® (esketamine nasal spray): treatments that were once considered unconventional and are now recognized as breakthrough therapies by the FDA. 

We understand what it means to work with powerful, fast-acting compounds under rigorous medical supervision, and we have built our clinical model around exactly that kind of care.

Keta Medical Center is actively preparing to offer psilocybin-assisted therapy in the future. We have been monitoring the clinical literature, studying the treatment models being developed by leading research institutions, and evaluating how this therapy could be integrated into the kind of physician-led, evidence-based care we already provide. 

That said, we will only offer psilocybin-assisted therapy once psilocybin has received full FDA approval and is clearly proven to be both safe and effective. This is not a bureaucratic position: it reflects our core commitment to patient safety and regulatory compliance. The executive order accelerates a process — it does not conclude one. And we will not move ahead of the science or the regulatory framework, no matter how promising the early evidence may be.

We are not speculating on a specific timeline for when psilocybin will receive FDA approval or when we will begin offering this service. What we can say is that when the moment comes, we will be ready and our patients will hear about it directly from us.

 

What psilocybin therapy at Keta Medical Center could look like

 

If and when psilocybin receives full FDA approval, we envision integrating psilocybin-assisted therapy into Keta Medical Center’s existing model of care in a way that reflects the same clinical rigor we apply to all of our treatments today.

Based on what the current clinical research suggests, psilocybin-assisted therapy would likely involve a structured, multi-phase process:

  • Initial screening and suitability assessment to determine whether a patient is an appropriate candidate. 
  • Preparatory sessions to establish therapeutic goals and clinical context; 
  • One or more physician-supervised dosing sessions conducted in a safe, controlled clinical environment. 
  • Integration support to help patients process and apply their experience following treatment. 

When approved, this therapy would initially be most appropriate for patients with treatment-resistant depression. It is also being studied in patients with PTSD who have not responded adequately to standard treatments. These are the same populations the executive order itself identifies as the primary intended beneficiaries.

For many of these patients, Keta Medical Center is already a point of care. Our vision of psilocybin-assisted therapy is that it would serve as a natural extension of what we already do: offer evidence-based treatment options for people who have seen limited to no success with conventional treatments.

 

How Keta Medical Center is helping patients today

 

While the regulatory landscape for psychedelic medicine continues to evolve, Keta Medical Center already provides proven, FDA-approved treatments for serious mental health conditions right now, across our five locations in the New York metropolitan area.

Spravato vs IV Ketamine Infusion

Treatment comparison — Keta Medical Center

Side-by-side comparison of Spravato (esketamine) nasal spray and IV ketamine infusion therapy offered at Keta Medical Center.
Spravato IV Ketamine Infusion
FDA approval FDA approved Off-label for mental health
Administration Nasal spray, administered in clinic Intravenous infusion, administered in clinic
Session length Approximately 2 hours Approximately 1–2 hours
Supervision Full medical supervision required Full medical supervision required
Best for Patients with treatment-resistant depression; those who prefer a non-IV option Patients with depression, anxiety, PTSD, and chronic pain who need rapid symptom relief
Insurance Covered by most major insurance plans when criteria are met Typically out-of-pocket

Both treatments are administered by our board-certified clinical team in a private, supervised setting. We provide comprehensive intake assessments, personalized treatment planning, and ongoing support throughout your care.


Schedule a free phone consultation to learn whether ketamine therapy or Spravato may be right for you.

The post Trump’s Psychedelic Executive Order: What It Means for Mental Health Treatment appeared first on Keta Medical Center.

]]> Is Psilocybin Legal? What Patients Should Know in 2026 https://ketamc.com/blog/is-psilocybin-legal/ Wed, 10 Jun 2026 14:29:32 +0000 https://ketamc.com/?p=18840 Psilocybin therapy is moving closer to mainstream medicine, but the legal picture is more complicated than recent headlines suggest. We break down federal vs. state law, the impact of the 2026 executive order, and what patients can access right now.

The post Is Psilocybin Legal? What Patients Should Know in 2026 appeared first on Keta Medical Center.

]]>

Psilocybin, the active compound in ‘magic mushrooms’, is generating significant attention in mental health and medical communities, and many people want to understand its legal status before speaking with their doctor about it.

A 2026 executive order has accelerated federal research and FDA review of psychedelic therapies, but psilocybin remains a Schedule I controlled substance at the federal level. That distinction matters, and this article will clarify it in detail.

Below, we explain the current legal landscape, what the new policy changes actually mean, what psilocybin therapy looks like in clinical practice, and how Keta Medical Center would offer it if and when regulatory pathways allow.

The 2026 executive order on psychedelics: A quick overview

On April 18, 2026, President Trump signed an executive order titled Accelerating Medical Treatments for Serious Mental Illness. The order speeds up FDA review of promising psychedelic drugs, puts $50 million toward research, and makes it easier for eligible patients to try these treatments before they are fully approved.

It’s important to clarify what the executive order does not do. It does not legalize psilocybin, approve it for medical use, or change its Schedule I status. 

It does, however, accelerate the federal research and review process. Final approval still requires completion of Phase 3 clinical trials and standard FDA evaluation.

Following the executive order, there has been significant discussion regarding the potential for Commissioner’s National Priority Vouchers to accelerate review timelines. While companies have applied for these vouchers—which could compress review timelines to one or two months—the granting of such vouchers remains subject to ongoing regulatory and political review, and their status is not yet confirmed.

So, is psilocybin legal?

At the federal level: no. Psilocybin is currently classified as a Schedule I controlled substance under the federal Controlled Substances Act, the most restrictive category, reserved for substances deemed to have no accepted medical use and high potential for abuse.

At the state level, the picture is more nuanced. Oregon and Colorado have legalized regulated psilocybin therapy programs for adults. In 2025, New Mexico also legalized a regulated market. Several other states have decriminalized personal possession or are actively advancing legislation. State laws vary significantly and continue to evolve.

There is one additional pathway: clinical trials. Psilocybin can be administered legally in the U.S. under FDA-supervised clinical trials. Patients enrolled in approved trials can access therapeutic psilocybin in a monitored medical setting, even in states where it’s otherwise prohibited.

When is psilocybin going to be legal?

There is no confirmed federal legalization date for psilocybin. However, the regulatory environment is evolving faster than at any point in recent history, and several developments are worth following closely.

For federal approval to occur, psilocybin must:

  • Complete Phase 3 clinical trials demonstrating safety and efficacy
  • Receive a positive FDA review
  • Potentially be rescheduled by the DEA from Schedule I to a lower schedule

The 2026 executive order accelerates FDA review timelines but does not eliminate these requirements.

As of May 2026, two psilocybin programs, Compass Pathways’ COMP360 and the Usona Institute’s formulation, have received FDA priority vouchers, placing them at the front of the review queue. If Phase 3 data support approval, expedited review could significantly accelerate the timeline to market.

Patients in Oregon, Colorado, and New Mexico can access regulated psilocybin therapy now. Additional states are advancing legislation. Patients interested in current access may explore whether a licensed program exists in their state.

At Keta Medical Center, we are actively monitoring the regulatory landscape and preparing to offer psilocybin therapy as soon as approved pathways are available in New York and New Jersey.

What is psilocybin therapy, and who is it for?

Psilocybin therapy is a clinician-supervised, structured treatment that pairs a carefully dosed psilocybin experience with preparation sessions before and integration support afterward. It’s not a recreational experience: it takes place in a monitored medical setting, guided by trained clinicians who help patients process what arises during the session.

Current clinical research has examined psilocybin therapy as a potential treatment for a range of conditions, including:

  • Treatment-resistant depression
  • Major depressive disorder
  • Post-traumatic stress disorder (PTSD)
  • Generalized anxiety disorder
  • End-of-life anxiety in patients with life-threatening illness
  • Alcohol use disorder and other substance use disorders

A typical psilocybin therapy protocol involves one to three preparatory sessions with a therapist, a single supervised dosing session lasting four to six hours in a calm, carefully controlled environment, and one or more integration sessions afterward to help the patient make meaning of the experience.

Potential benefits observed in clinical settings include sustained reductions in depressive symptoms, improvements in emotional openness and psychological flexibility, and a reported sense of connectedness or perspective shift that outlasts the session itself.

Does Keta Medical Center offer psilocybin therapy?

Not yet. Psilocybin currently remains a Schedule I controlled substance federally, which means it cannot be administered outside of approved clinical trials in most states. Keta Medical Center operates within that regulatory framework and does not currently offer psilocybin therapy.

That said, we are closely following the evolving regulatory landscape and are preparing to integrate psilocybin-assisted therapy into our care model when approved pathways become available, and if the scientific evidence clearly shows that it is both safe and effective.

Our background in ketamine-assisted psychotherapy has given us direct experience with psychedelic-adjacent treatments in clinical settings: physician oversight, carefully managed therapeutic environments, patient preparation, and post-session support. These are the same pillars that define effective psilocybin therapy in research settings.

Ketamine therapy, which we offer today, works in many of the same ways as psilocybin in the brain and has strong clinical evidence for treatment-resistant depression and other mental health conditions. It may be an appropriate option while broader regulatory approvals are pending.

Interested in learning more about ketamine therapy, how much it costs, and if it’s right for you? 

Schedule a free phone consultation with our team to discuss your treatment options.

The post Is Psilocybin Legal? What Patients Should Know in 2026 appeared first on Keta Medical Center.

]]> Part 2: When Insight Isn’t Enough: How Ketamine-Assisted Psychotherapy Helps Patients Heal From Trauma https://ketamc.com/blog/spravato-ketamine-psychotherapy-trauma/ Tue, 31 Mar 2026 20:01:40 +0000 https://ketamc.com/?p=18279 For many trauma survivors, understanding what happened isn’t enough to feel better. This article explores how Spravato and ketamine-assisted psychotherapy (KAP) work together to help process trauma, shift long-standing patterns, and support deep emotional healing.

The post Part 2: When Insight Isn’t Enough: How Ketamine-Assisted Psychotherapy Helps Patients Heal From Trauma appeared first on Keta Medical Center.

]]>

How Spravato and Ketamine-Assisted Psychotherapy Work Together

This article is the second of a two-part series examining how Spravato® and ketamine-assisted psychotherapy (KAP) complement each other in the treatment of depression. Read the companion article: Life After Treatment-Resistant Depression.

Many trauma survivors reach a point in therapy where they intellectually understand what happened to them. They know the event was not their fault, can articulate the experience and explain it clearly. Yet that insight doesn’t relieve the emotional weight of the trauma.

Shame, self-blame, and painful body memories can persist long after the mind understands the truth. For some patients, this is where traditional therapeutic approaches stop short of helping them move towards meaningful change.

Spravato and ketamine-assisted psychotherapy offer a different approach

At Keta Medical Center, we often combine Spravato, a ketamine-based nasal spray, with ketamine-assisted psychotherapy (KAP) to help patients move beyond intellectual insight and toward deeper emotional healing.

Spravato works differently from traditional antidepressants. It affects the neural pathways in the brain and increases its capacity for neuroplasticity – the brain’s lifelong ability to reorganize its structure, functions, and neural connections in response to learning or experience. When this biological process is paired with psychotherapy, patients can often look at difficult memories and long-standing emotional patterns from a new perspective.

Ketamine-assisted psychotherapy is an integrated process. Treatment typically begins with one or more preparation sessions, where therapist and patient explore personal history, identify goals, and establish intentions for the work ahead. These conversations help build trust and prepare patients for the experiences that may arise during ketamine sessions.

A life burdened by the weight of trauma

During ketamine treatment sessions patients enter a dream-like or altered state of consciousness. Some describe deep relaxation, while others encounter vivid memories, images, or emotional insights. This state can create enough psychological distance for patients to observe painful experiences without feeling flooded by them.

In my work as a therapist, I often witness how meaningful this shift in perspective can be. Here’s an example of what this can look like for a patient. Please note that the story below is not based on the experience of any one single patient. Rather, it’s a blend of experiences I have seen across many patients. I have carefully changed details to protect the privacy and identity of all of my patients.

A middle-aged woman struggles with lifelong feelings of shame after being sexually assaulted as a teenager. She has undergone years of therapy but nothing really helps her move forward. She feels uncomfortable in her own skin, hating her body and overeating to block out the feelings of depression and shame.

Over time, she tries many different things to heal. She joins an overeaters anonymous group. She participates in various therapies where therapists tell her it wasn’t her fault. She also joins women’s support groups. She finds comradery in these groups and appreciates the support, yet the heavy depression and shame remain.

She hears therapists say that what happened was not her fault, and cognitively she is able to agree with it. But her body still feels heavy, and she continues to bury her depression with food. After episodes of binge eating, the shame and heaviness become even more intense.

A new perspective on traumatic memories

Antidepressants help numb the depression, but she still struggles with overeating and a vague sense of unease. She finds support in good friendships and trusts her therapist, but the words “it’s not your fault” never seem to penetrate deeply. Day after day, she feels as though she is simply slogging through life, carrying the same burden while gaining more and more weight. When she begins treatment with Spravato alongside ketamine-assisted psychotherapy, something changes.

During one of her early Spravato sessions, she revisits the memory of the assault in a way she has never experienced, from a distance, almost like watching a movie. She sees her younger self, thin and unprotected. She remembers the smells and the details of the attack. She recalls the physical and emotional humiliation and the pain. She remembers feeling shame, but she doesn’t relive the trauma with overwhelming emotions. It is as if she is observing her former self.

Afterwards, she writes about what she has experienced and brings those reflections into her ketamine-assisted psychotherapy sessions. This is where integration therapy becomes central to the healing process. Integration sessions typically occur within a day or two after treatment, while the brain is still more flexible and receptive to new perspectives. During these sessions, patients explore the emotions and insights that emerged during ketamine treatment and begin translating them into meaningful change.

Challenging the story that had defined her for years

Together, we began examining the details that had reinforced her self-blame for years. She remembered wearing a short skirt that day, smiling at her perpetrator, and not reporting the crime immediately.

As her therapist, I questioned the ingrained assumptions hiding behind these memories. Does smiling at someone mean she caused the assault? Does what someone wears make them responsible for violence? Does not reporting immediately mean the experience was somehow less serious? Looking at these details within ketamine-assisted psychotherapy slowly led her to challenge the narrative she has held onto for decades.

Shifting from shame to lightness

Within weeks of beginning treatment, the woman noticed a meaningful shift. She ate meals without constantly counting calories, actually enjoying the food. For the first time in years, she wore clothes that fit her body instead of hiding beneath oversized layers. She described feeling lighter overall and free from the shame that had burdened her for decades.

For many trauma survivors, that kind of shift is transformative. Ketamine-assisted psychotherapy offers a structured way to explore painful experiences, process difficult emotions, and reshape long-standing beliefs. When Spravato treatment is combined with thoughtful therapeutic work, patients may find themselves able to release patterns that have defined them for years. And that opens the door to true healing.

If you are struggling with the lasting effects of trauma and treatment-resistant depression, Spravato® treatment combined with ketamine-assisted psychotherapy may offer a new path toward healing. Schedule a free consultation with a clinician at Keta Medical Center to see whether this approach may be appropriate for you.

The post Part 2: When Insight Isn’t Enough: How Ketamine-Assisted Psychotherapy Helps Patients Heal From Trauma appeared first on Keta Medical Center.

]]> Part 1: ​​Life After Treatment-Resistant Depression https://ketamc.com/blog/spravato-ketamine-psychotherapy-depression/ https://ketamc.com/blog/spravato-ketamine-psychotherapy-depression/#comments Tue, 31 Mar 2026 02:55:18 +0000 https://ketamc.com/?p=18358 Learn how Spravato and ketamine-assisted psychotherapy help patients with treatment-resistant depression rebuild their lives.

The post Part 1: ​​Life After Treatment-Resistant Depression appeared first on Keta Medical Center.

]]>

How Spravato and Ketamine-Assisted Psychotherapy Work Together

This article is the first of a two-part series examining how Spravato® and ketamine-assisted psychotherapy (KAP) complement each other in the treatment of depression. Read the companion article: When Insight Isn’t Enough: How Ketamine-Assisted Psychotherapy Helps Patients Heal From Trauma.
Severe depression takes away joy, identity, connection with others, and any sense of progress in life. Many people living with treatment-resistant depression (TRD) find they are enduring life rather than participating in it.

I have worked with patients who have spent 10, 15, even more than 20 years trying different antidepressants. The medications may help them function — they manage to get to work, pay bills, attend family events — but inside, they feel exhausted and emotionally absent. This long-term survival mode can profoundly affect marriages, parenting, friendships, and self-esteem.

 

Ketamine treatment creates a window for change

When we begin treating them with Spravato®, a nasal spray based on the ketamine derivative esketamine, something often begins to shift. Unlike traditional antidepressants, esketamine works through different neurobiological mechanisms that promote neural plasticity and cognitive flexibility.

Simply stated, the brain becomes more open to change. Research suggests this creates a temporary “window” in which psychotherapy can take a deeper root. Combining ketamine treatment with ketamine-assisted psychotherapy may enhance and sustain the beneficial treatment effects, as the same study finds. In my experience with patients, this is absolutely the case.

We often see the first signs of relief within days of beginning treatment. But after years, even decades, of emotional numbness, many patients find themselves asking: Now what? This is where ketamine-assisted psychotherapy comes in.

 

A man living with 15 years of severe depression

In my work, I often see a pattern like in the following story, which is a composite drawn from many patients: Imagine someone who’s lived with treatment-resistant depression for over 15 years and has tried every antidepressant available.

The medications help him drag himself through each day. At work, he does enough to get by, then closes his office door and rests his head on his desk between meetings. He stays in his office because he doesn’t have the energy to chat with colleagues.

Pushing down a granola bite for lunch is an effort. He feels the sensation of hunger but has no appetite. After work, he comes home and forces a weak smile to his wife and young daughter before heading straight to bed. His wife has gotten used to doing everything at home, from household chores to childcare.

On Sundays, his daughter asks for “daddy time.” He takes her to the park out of guilt, but every step feels like climbing a mountain. All he wants is to get back home and get into bed.

This all changes with Spravato. After a couple of sessions, he feels lighter. Small things begin to improve. At work, he notices that the food his colleagues bring smells good, and for the first time in years, he wants to try it. Two weeks after starting Spravato, he eats a full deli sandwich and can’t believe how good it tastes.

When a colleague knocks on his door during his break, he is able to smile and engage in small talk without it feeling like a huge exertion. Then he comes home from work and sits at the table with his wife and daughter for dinner. They can’t believe it.

Yet unexpectedly, the improvement also makes him feel overwhelmed. For years, he has been in survival mode. While he now feels relief from his depression, he doesn’t know what to do first, how to re-enter the life he’s been absent from, and how to repair the relationships that have adapted to his emotional distance.

 

Rebuilding connection after years of absence

Ketamine-assisted psychotherapy (KAP) helps him contain his feelings and figure out which part of his life he wants to address first. As his depression lifts, his first priority is being there emotionally for his daughter and wife. But how does he do that?

With the help of KAP, he finds the language to explain to his daughter what it meant that daddy was depressed, and what it means that he is getting better. He talks through how to reconnect with his wife.

When symptoms improve, patients often become aware of the patterns they’ve cemented around the burden they’ve carried. The patient has to relearn how to show up emotionally, how to communicate openly, and how to rebuild trust with his loved ones. The medication has energized him, and ketamine-assisted psychotherapy is helping him find his way forward.

 

From symptom relief to long-term recovery

Ketamine treatment may open the door. Therapy helps patients walk through it. In my work, I integrate cognitive behavioral therapy (CBT) and internal family systems (IFS).

Without additional support, the benefits of ketamine treatment may be short-lived, according to a clinical study. In the study, those receiving intravenous ketamine treatment who engaged in concurrent cognitive behavioral therapy (CBT) had lower relapse rates. In another study, patients who received ketamine infusions alongside psychotherapy showed more pronounced symptom reduction than those who received infusions alone.

CBT helps patients examine long-standing thought patterns, such as “I’m a burden,” “I’ve wasted my life,” “It’s too late to change”. It helps reframe those beliefs while building concrete behavioral changes. IFS helps individuals understand and integrate parts of themselves shaped by trauma, shame, or self-criticism.

The neuroplastic window created by Spravato presents an opportunity, but it can feel disorienting. In that space, ketamine-assisted psychotherapy helps to reflect deep insights gained in ketamine sessions and integrate them into daily life, creating lightness, connection, a sense of fulfillment and calm, and even joy.

If you’re struggling with treatment-resistant depression, Spravato and ketamine-assisted psychotherapy may offer a new path forward. Schedule a free consultation with a clinician at Keta Medical Center to explore whether this approach is right for you.

The post Part 1: ​​Life After Treatment-Resistant Depression appeared first on Keta Medical Center.

]]> https://ketamc.com/blog/spravato-ketamine-psychotherapy-depression/feed/ 1 Are You Anxious, Depressed, or Suffering From PTSD? The Answer is Complex, But Crucial https://ketamc.com/blog/anxiety-depression-ptsd-diagnosis/ Fri, 20 Mar 2026 09:00:24 +0000 https://ketamc.com/?p=17556 Anxiety, depression, and PTSD often look similar—but they are not the same. Understanding where these conditions overlap, how trauma plays a role, and why accurate diagnosis matters is critical to getting the right treatment.

The post Are You Anxious, Depressed, or Suffering From PTSD? The Answer is Complex, But Crucial appeared first on Keta Medical Center.

]]>
We often use the terms “anxious”, “depressed”, and “traumatized” interchangeably in everyday conversation. Yet in clinical practice, these words refer to distinct mental health conditions. They share common symptoms, but they also have distinct diagnostic features.

Many of the classic symptoms of anxiety, depression, and post-traumatic stress disorder (PTSD) look strikingly similar on the surface. Difficulty sleeping, fatigue, trouble concentrating, and impaired daily functioning appear in all three diagnoses. The overlap can lead to confusion, both for individuals experiencing symptoms and the clinicians trying to untangle them.

To get the treatment right, you first need an accurate diagnosis. That’s why it’s so important to understand how these conditions differ and where they overlap.


A National Mental Health Snapshot

According to the National Alliance on Mental Illness, anxiety disorders affect 19.1% of U.S. adults each year, making them the most common mental health condition. Major depressive disorder follows at 15.5%. Post-traumatic stress disorder (PTSD) is also a leading diagnosis, though significantly less common, affecting 4.1% of adults annually. While PTSD is the third most prevalent condition listed, it is less than a quarter as common as anxiety. It’s also much less frequently recognized in clinical settings.

Symptoms like changes in mood, sleep, concentration, or behavior are common signs of mental health conditions, but they don’t point to a specific diagnosis on their own. That’s why clinicians don’t make an assessment based just on individual symptoms. Instead, they consider how long the symptoms have lasted, how they cluster together, and how much they interfere with daily functioning.


Breaking Down the Big Three

Anxiety disorders are defined by excessive worry, physical tension, restlessness, and a sense of impending doom. Generalized anxiety disorder (GAD), for example, affects around 6.8 million adults in the U.S., but fewer than half receive treatment.

Major depressive disorder (MDD) impacts more than 17 million adults and is marked by persistent sadness, lack of pleasure, low energy, and feelings of worthlessness. Unlike temporary emotional dips, depression disrupts daily functioning for weeks or months.

PTSD is a specific, direct psychiatric response to trauma. It has clearly defined diagnostic criteria that are explicitly linked to a traumatic event. Symptoms such as hyperarousal, intrusive memories, avoidance, and negative changes in mood and thinking typically begin after the trauma and are triggered by it.

According to the American Academy of Family Physicians, approximately 25 to 30 percent of victims of significant trauma develop PTSD. While once thought to be limited to soldiers or disaster survivors, PTSD is now understood to be the result of various types of traumatic events, including emotional and physical abuse, medical trauma, or loss.


Mental Health Disorders Resulting From Trauma

What makes these disorders hard to differentiate? One reason is that the human brain doesn’t compartmentalize emotional suffering neatly. Not only do anxiety, depression and PTSD have overlapping symptoms, but they can also co-exist.

To begin with, it is important to separate trauma from the reaction to it. Trauma itself is not PTSD. People can develop PTSD following a traumatic experience, though the majority do not.

Depression and anxiety can also be trauma-related, even though they’re usually not exclusively caused by trauma. When they are, the connection is often less immediate or obvious than in the case of PTSD. For instance, someone may develop depression years after a traumatic experience due to prolonged emotional distress, rather than vivid trauma memories. Others may struggle with anxiety rooted in early-life experiences they no longer consciously remember as traumatic.

In short, while PTSD is the most direct diagnostic expression of trauma, anxiety and depression may arise from it indirectly, develop gradually, or be influenced by other causes entirely.


The Overlap Problem

A 2024 study published in Nature found that two core hallmarks of PTSD are strongly associated with symptoms of both anxiety and depression. The study focused on hyperarousal, which refers to a state of constant tension or an exaggerated startle response, and intrusion, which involves distressing, unwanted memories of the traumatic event.

The study concludes that PTSD symptoms can mimic anxiety and depression. As multiple studies show, this contributes to frequent misdiagnosis, with PTSD often mistaken for depression, anxiety, or another condition entirely. This underscores the importance of trauma screening and detailed assessment in clinical care.

At the same time, the impairments and symptoms suffered by someone with PTSD can, in turn, cause the other two conditions. In that case, PTSD will coexist with depression, anxiety, or both. The National Institute of Mental Health notes that 50% of people with PTSD also meet criteria for major depression.

While misdiagnosis most often applies to PTSD, telling anxiety and depression apart is not straightforward, either. They, too, have overlapping symptoms and frequently occur together. They can also be a result of a history of trauma that, while it didn’t lead to PTSD, has gone undiagnosed or untreated.

These blurred lines make diagnosis challenging, but crucial. Why? Because treatments that work for one condition might not help, or even worsen, another.


The Importance of Accurate Diagnosis and Treatment

Traditional symptom checklists often fail to capture the complex interplay of trauma and mood symptoms. The same person could be treated with a classic medication for anxiety, when in fact they are experiencing PTSD-related hyperarousal. That means they would most likely respond better to trauma-focused therapy or, depending on the patient’s needs, to ketamine treatment and ketamine-assisted psychotherapy (KAP).

Depression and anxiety are also important to tell apart. Medications like Wellbutrin are approved for depression but not anxiety, and can sometimes even worsen anxiety symptoms. On the other hand, medications like Buspar are used for anxiety but have no benefit for depression.

Therapy, too, must be targeted to the emotional core of the condition: whether it’s the deep sadness, emptiness, and hopelessness that characterizes depression or the, or the fear, worry and catastrophic “what if” thinking that points to anxiety.

While antidepressants and cognitive behavioral therapy are standard treatments for depression and anxiety, PTSD-related symptoms may require different approaches. The National Institute of Mental Health highlights evidence-based treatments like EMDR (Eye Movement Desensitization and Reprocessing) and trauma-informed CBT for individuals with PTSD. Some may also benefit from ketamine treatment, which has shown promise in treating both trauma-related disorders and treatment-resistant depression.

At Keta Medical Center, we work closely with your psychiatrist, if you have one, to ensure coordinated care. Our team has the in-house expertise to understand the full picture and determine whether ketamine therapy is an appropriate next step.
Schedule a free consultation

The post Are You Anxious, Depressed, or Suffering From PTSD? The Answer is Complex, But Crucial appeared first on Keta Medical Center.

]]> You Have Nothing to Lose: How Lori Found Happiness After a Lifetime of Depression https://ketamc.com/blog/you-have-nothing-to-lose-how-lori-found-happiness-after-a-lifetime-of-depression/ Thu, 19 Mar 2026 05:44:06 +0000 https://ketamc.com/?p=18220 This article orginally appeared in Tap Into. Patient Lori shared her experience at Keta Medical Center.

The post You Have Nothing to Lose: How Lori Found Happiness After a Lifetime of Depression appeared first on Keta Medical Center.

]]>
This article appeared in Tap Into Westfield. Patient Lori shared her experience at Keta Medical Center.
 

Lori, a 72-year-old retiree from Fair Lawn, NJ, has weathered a lifetime of emotional struggles. Diagnosed with treatment-resistant depression, she spent most of her adult life searching for treatments that could bring relief.

“I was probably a depressed kid,” she said. “But back then, I just thought that’s how life was.”

First diagnosed with depression in her mid-20s, Lori spent the decades that followed trying to manage her condition through therapy and a multitude of medications. Some treatments offered periods of relief, followed by setbacks. One medication in particular caused unbearable side effects, leading to a traumatic episode that left her deeply distrustful of her medical caretakers.

About four years ago, she started treatment with Spravato, a nasal spray form of a drug called ketamine that’s approved by the FDA to alleviate treatment-resistant depression. Ketamine targets brain chemicals differently than traditional antidepressants and can provide rapid relief when nothing else works.

After a lifetime of suffering, ketamine greatly helped Lori with her depression. But she felt uneasy with the clinic’s inconsistent care and lack of support. “Sometimes the doctor wasn’t even there during the treatment. Once during a session I suddenly got very scared, and no one knew what to do.”

Everything changed when Lori transferred to a clinic called Keta Medical Center. 

“Everyone there was wonderful. Dina, this one nurse, was like my angel,” Lori said. “She told me, ‘You need to prime yourself, get yourself in a calm head before the treatment.’ Because when you’re doing this, you get kind of trippy. No one had explained these things to me before.”

Until then, Lori would bring psychological thrillers to read during her sessions, books she loved, but that could trigger disturbing thoughts. Now, she knows to bring lighter reading, and she tucks baby pictures of her daughter inside the book. “Spravato is really bitter and can make you nauseous. Dina gave me chocolate kisses, so after each dose I have something sweet. All these small things matter so much.”

Most importantly, there was always a doctor on-site at the new clinic, ready to help if needed. After one intense session, a physician Lori particularly connected with helped her calm down and made sure to follow up and see how she was doing the next day.

Today, Lori enjoys volunteering regularly, connects more easily with her loved ones, and feels better equipped to manage her health. 

“I’m not euphoric,” she said, “but I’m definitely much happier.” To others struggling with persistent depression, Lori has a simple message: “I’d say try ketamine treatment. You have nothing to lose, only to gain.”

Keta Medical Center, where Lori is being treated, recently opened a new clinic in Westfield, NJ. The newest location provides a physician-led, evidence-based approach to ketamine therapy for individuals in Central New Jersey who are living with depression, anxiety, PTSD and other mental health conditions. By combining the innovative treatment with personalized support and close coordination with patients’ existing providers, Keta Medical Center offers something many people have long been searching for: A path to healing and lasting relief.

Schedule a free consultation

The post You Have Nothing to Lose: How Lori Found Happiness After a Lifetime of Depression appeared first on Keta Medical Center.

]]> Is the Tech Industry Facing a Mental Health Crisis? https://ketamc.com/blog/tech-industry-mental-health-crisis-burnout-depression/ Wed, 11 Mar 2026 09:00:47 +0000 https://ketamc.com/?p=17831 The tech industry thrives on innovation and speed-but beneath the surface, many professionals are struggling with burnout, anxiety, and depression. From engineers to executives, high performance often masks deep mental health challenges. This article explores why tech workers are at higher risk and what meaningful recovery can look like.

The post Is the Tech Industry Facing a Mental Health Crisis? appeared first on Keta Medical Center.

]]>
The tech industry offers a fast-moving, intellectually stimulating, creative and constantly evolving work environment. But the flipside of it is a workplace culture that often pushes human limits, demanding nonstop output, constant problem-solving, and a tolerance for chronic stress. In fact, a global survey of over 32,000 tech professionals found that 62% feel physically and emotionally drained by the demands of their job.

It’s no wonder, then, that beneath the surface of the high achievement lies a growing mental health crisis. From developers and engineers to product managers and C-level executives, professionals across the industry are reporting increased stress, burnout, anxiety and symptoms of depression.

Cybersecurity professionals are particularly affected. Their work demands constant vigilance, high responsibility, and, frequently, a 24/7 readiness to respond to unpredictable threats. The emotional and cognitive toll of this environment manifests in real, measurable mental health concerns.


Research points to a widespread challenge

Professionals in the tech industry generally face an up to five times higher risk of depression than other employees, studies show. This alarming disparity highlights how relentless pressure to stay on top of emerging trends, hit tight deadlines, and manage complex workloads can contribute to mental health problems. Blurred boundaries between work and personal life intensify the problem, negatively impacting both job performance and overall well-being.

A 2025 study showed that workplace stressors specific to cybersecurity, such as frequent exposure to alerts and protocols, increase the likelihood of burnout and reduce mental well-being. The 2024 ISC2 Cybersecurity Workforce Study found that job satisfaction rates in cybersecurity fell to 66% in 2024, with burnout widely cited as a primary factor.

Mental health challenges also affect leaders in the tech industry, including CEOs and other C-suite executives. Many report heightened stress, difficulties collaborating virtually, and a sense of isolation in their roles, research shows. Some experience symptoms like fatigue, mood shifts, low motivation, and disrupted sleep, yet few feel they can seek help.

Without proper support, business leaders may turn to unhealthy coping strategies, underscoring the need to treat mental health at the leadership level as a serious concern.


High-performance environments can generate a sense of isolation

Culturally, the tech industry is known for celebrating diligence, optimism and self-reliance. This can make it difficult for individuals to admit when they’re struggling. Seeking help is sometimes seen as a weakness, especially in high-performance teams where others appear to be thriving.

Younger professionals have proven to be especially vulnerable. Entry-level roles are often tasked with demanding, time-consuming tasks, with their contributions rarely acknowledged. This invisibility, combined with high expectations, can contribute to imposter syndrome, where techworkers doubt their skills even when they are performing well.


From warning signs to intervention

Depression in tech professionals often shows up as irritability, fatigue, disengagement, and mental fog. Some describe feeling emotionally exhausted, numb or stuck, unable to focus and make decisions. These symptoms are warning signs, and early intervention is essential. A combination of self-awareness, supportive practices, and professional care can make a huge difference.

A few key habits can help tech professionals to protect their mental health. Establishing clear boundaries around work hours and availability is critical in order to disconnect from work and give the nervous system time to recover. Maintaining consistent sleep and practicing mindfulness, yoga, or physical movement can help regulate stress and support overall resilience. And connection with others is vital, whether through therapy, peer groups, or trusted colleagues.

When daily uncertainty becomes overwhelming, small, deliberate actions can help rebuild a sense of clarity and control. Here are seven practical tips to help manage the mental load:

  1. Set micro-boundaries: Turn off alerts after hours or set brief buffers between tasks.
  2. Schedule real rest: Take brief screen-free breaks to regulate your nervous system.
  3. Externalize worries: Write down concerns and identify what is within your control.
  4. Reset your nervous system quickly: Techniques like cold exposure, short bursts of movement, deep breathing, and muscle relaxation help manage acute stress.
  5. Reframe uncertainty: Use affirmations like “I can handle things as they come” or “Not knowing isn’t dangerous.”
  6. Complete one small task at a time: Find a task with a clear “done” moment to regain a sense of control.

Research has shown that interventions like digital detox and structured recovery practices reduce the negative impact of tech-related fatigue.


An alternative path to recovery

For some people suffering from burnout, workplace depression, or other mental health challenges connected to a high-pressure work environment, traditional approaches such as therapy may not be enough. When depression becomes treatment-resistant or lifestyle changes simply seem impossible to implement, alternative treatments like ketamine may provide the breakthrough needed to begin healing.

Ketamine therapy can provide lasting relief from depression and support emotional resilience. Unlike most antidepressants, which take weeks to show effects, ketamine acts quickly and can help break through patterns of emotional shutdown and cognitive overload.

At Keta Medical Center, we offer individualized ketamine treatments in a medically supervised, compassionate setting. Our programs are designed to support those who haven’t found relief through other methods, including professionals facing persistent burnout, anxiety, or depressive symptoms linked to high-stress work.
Schedule a free consultation

The post Is the Tech Industry Facing a Mental Health Crisis? appeared first on Keta Medical Center.

]]> Thinking about At-Home Ketamine Treatment? Think Twice! https://ketamc.com/blog/at-home-ketamine-treatment-risks/ Mon, 22 Jul 2024 12:44:06 +0000 https://ketamc.com/?p=2821 Learn the risks of at-home ketamine treatment, and why it’s less effective than treatment received in a professional setting.

The post Thinking about At-Home Ketamine Treatment? Think Twice! appeared first on Keta Medical Center.

]]>

In recent years, ketamine has become something of a buzzword among patients looking to treat such conditions as PTSD, depression, and anxiety. Ketamine offers a lot of benefits and is sometimes reported as more effective than traditional therapy, particularly for people who have failed to find relief from traditional treatments. But the growing popularity has its drawbacks: the cases of self-administering ketamine at home are rising, and the notion of medical supervision as non-essential is becoming increasingly widespread. That is where the danger lurks: at-home ketamine use without professional oversight carries many risks and side effects, is less effective, and can lead to unpredictable outcomes.

In recent months, these dangers have made front page news as more details emerge about the tragic death of actor Matthew Perry from the acute effects of ketamine.

The potential complications of at-home ketamine are numerous, but most often problems arise from poor dosage management and the absence of post-consumption supervision – patients simply can’t be both patients and doctors. Self-administration often leads to abuse and misuse. At-home treatment is neither advisable nor desirable and here’s why.

Key Risks of At-Home Ketamine Treatment

1. Lack of Effectiveness

At-home treatments are available as injections or pills. While pills sound appealing, they are generally not bioavailable because they pass through the stomach where much of the effective ingredients are lost. The amount of ketamine that reaches the bloodstream is very small rendering this method less efficient and effective than injection. As a result, patients have to wait long time periods to find any relief from the pills, and many give up.

2. Safety Concerns and Potential for Misuse

With injections, on the other hand, it can be difficult to get the dosage right, leading to serious and sometimes life-threatening risks. There are many documented cases where a patient has self-administered the wrong dosage with dangerous consequences.

While injections carry the obvious risk of overdose, pills pose risks as well. Because they require more time to take effect, patients desperate to find relief may consume more than the recommended dose.

Overdosing on ketamine, regardless of the delivery method, can exacerbate side effects such as hallucinations, high blood pressure, and even breathing problems.

Why Medical Oversight Is Essential with Ketamine Treatments


Avoid Adverse Side Effects

Common side effects of ketamine include dizziness, nausea, increased heart rate, and confusion. More severe side effects can include high blood pressure, hallucinations, and even respiratory issues.

Medical supervision is crucial to preventing the severe side effects associated with ketamine treatment. Doctors have gone through years of specialized training to learn how to determine each patient’s recommended course of treatment. They know exactly how to best administer the medication, monitor for any issues and respond as needed. At a ketamine clinic like ours, physicians look after the patient and can quickly intervene in case of severe side effects, adjusting the treatment as needed to mitigate risks and ensure safety.

Receive Just the Right Dosage

Determining the right dosage of ketamine is essential to achieving the maximum therapeutic benefit and for minimizing risks. In a clinical setting, doctors use their expertise and experience to administer a precise dosage based on each patient’s specific needs and medical history. As a result, patients receive an effective therapeutic dose without risk. The home setting can’t offer the same precision and patients may overdose or discontinue the treatment too early.
 

Achieving Optimal Outcomes

While at-home ketamine treatment may seem convenient, the lack of efficacy, safety concerns, and a high potential for abuse can make it dangerous rather than helpful. Medical oversight is essential for safe, effective, and optimal treatment outcomes.

At Keta Medical Center, every treatment is supervised by a doctor, and both the dosage and treatment protocol are tailored to ensure the best therapeutic outcomes for each patient. This approach maximizes the effectiveness of the ketamine treatment while maintaining the highest safety standards. Our doctors assess each patient’s progress and make required adjustments in the treatment plan for the best results. This level of individualized care is essential for achieving the full therapeutic potential of ketamine, something that cannot be replicated in an unsupervised home setting.

Don’t go it alone. Always consult with a professional when it comes to receiving ketamine therapy. By doing so, you are far more likely to receive a treatment that is safe and effective, providing you with long term results and a better quality of life.

Considering Ketamine Therapy?
Book a Free Consultation.

The post Thinking about At-Home Ketamine Treatment? Think Twice! appeared first on Keta Medical Center.

]]>